CN106902092A - A kind of disintegration is fast(S)Oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2 and preparation method thereof - Google Patents

A kind of disintegration is fast(S)Oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2 and preparation method thereof Download PDF

Info

Publication number
CN106902092A
CN106902092A CN201510946805.XA CN201510946805A CN106902092A CN 106902092 A CN106902092 A CN 106902092A CN 201510946805 A CN201510946805 A CN 201510946805A CN 106902092 A CN106902092 A CN 106902092A
Authority
CN
China
Prior art keywords
parts
oxo
mixed
recipe quantity
hydroxyls
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201510946805.XA
Other languages
Chinese (zh)
Inventor
叶雷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Runze Pharmaceutical Co Ltd
Original Assignee
Chongqing Runze Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Runze Pharmaceutical Co Ltd filed Critical Chongqing Runze Pharmaceutical Co Ltd
Priority to CN201510946805.XA priority Critical patent/CN106902092A/en
Publication of CN106902092A publication Critical patent/CN106902092A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)

Abstract

It is a kind of(S)The pyrrolidine acetamide effervescent tablet of 4 hydroxyl, 2 oxo 1, it is obtained by following supplementary material:(S)1 part of 4 hydroxyl, 2 oxo, 1 pyrrolidine acetamide, 5 ~ 9 parts of tartaric acid, 5 ~ 9 parts of sodium acid carbonate, 0.2 ~ 0.7 part of sodium chloride, 0.3 ~ 1.05 part of Macrogol 6000,5 ~ 10 parts of dextrin, 0.7 ~ 1.2 part of Sucralose, 0.3 ~ 0.8 part of peppermint oil, 0.3 ~ 0.8 part of strawberry essence, volume fraction are 30% ~ 50% 18 ~ 25 parts of ethanol solution, 3 ~ 5 parts of sodium carboxymethylcellulose, 6 ~ 12 parts of microcrystalline cellulose;According to obtained in the present invention(S)The pyrrolidine acetamide effervescent tablet tableting processes of 4 hydroxyl, 2 oxo 1 will not sticking, finished product aerogenesis is fast, and disintegration is fast, and storage process is difficult moisture absorption and goes bad, it is easy to preserves, this product is in good taste, is easily received by most of patient, shelf life is 30 months.

Description

It is a kind of to be disintegrated fast oxo-1-pyrrolidine ethanamide effervescent tablet of (S) -4- hydroxyls -2 and preparation method thereof
Technical field
The invention mainly relates to pharmaceutical technology field, and in particular to a kind of fast oxo -1- pyrroles of (S) -4- hydroxyls -2 of disintegration Alkyl acetamide effervescent tablet and preparation method thereof.
Background technology
Oxiracetam was listed in 1987 in Italy, and the formulation of listing is tablet, 800mg;Capsule, 800mg;Note Penetrate liquid, 1g/5ml.Domestic at present only have oxiracetam capsule and parenteral solution listing, and main active used be it is outer Raceme.Caused by Ye Lei etc. mentions levo-oxiracetam to alcoholism in the A patents of Publication No. CN 103735545 The promoting wakening of stupor is obvious, and dextrorotation Oxiracetam is not acted on substantially, and the awake effect of above-mentioned rush of levo-oxiracetam is 2 times of racemization Oxiracetam;Levo-oxiracetam is notable to the promoting wakening of stupor caused by wound, anesthesia.Open peak etc. It is traumatic caused by levo-oxiracetam is disclosed in the patent of the A of Publication No. CN 103599101 to hydraulic pressure and freely falling body Brain injury in rats learning and memory cognition dysfunction improves significantly, and its drug effect is far above dextrorotation Oxiracetam. And 200mg/kg levo-oxiracetams are suitable with the effect of 400mg/kg Oxiracetams.Pharmacokinetic study results show: Levo-oxiracetam and dextrorotation Oxiracetam are in beasle dog body without obvious chiral inversion.Beasle dog single intravenous injection gives The main pharmacokinetic parameters of levo-oxiracetam nothing is substantially poor in blood plasma after left-handed and 2 multiple doses racemization Oxiracetam It is different.The result of the tests such as safe pharmacology, anxious poison malicious, long show, under isodose level, levo-oxiracetam and Aura It is western smooth to animal subject or the toxicity no significant difference of cell.Above-mentioned preclinical result of study shows, levo-oxiracetam It is the main active that drug effect is played in Oxiracetam body, this product is used alone can reduce Clinical practice dosage, reduces latent Toxicity.
Oxiracetam (oxiracetam, CAS No.:62613-82-5) chemical entitled 4- hydroxyls -2- OXo-1-pyrrolidine second Acid amides, is that (compound is disclosed in the anti anoxia class cereboactive drug that synthesized first in 1974 of Italian ISFS.P.A companies US4118396), it is ring GABOB derivatives, Phosphorylcholine and phosphatidyl ethanolamine can be promoted to synthesize, promotes brain metabolism, Through blood-brain barrier, have stimulation to specific nervous centralis road, intelligence and memory can be improved, to cerebrovascular disease, Brain trauma, brain tumor, intracranial infection, brain degenerative disease etc. also have preferable curative effect, and the drug toxicity is extremely low, nothing Mutagenesis and carcinogenesis and genotoxicity.Giorgio et al. discloses the chemistry knot of Oxiracetam in US4118396 Structure and preparation method, Chiodini et al. are disclosed in WO9306826A, and clinical effectiveness proves S's configurations (left-handed) The drug effect of Oxiracetam is better than R configurations (dextrorotation), and Oxiracetam and levo-oxiracetam structure are as follows.
The existing oxo-1-pyrrolidine ethanamide effervescent formulation of (S) -4- hydroxyls -2 be primarily present the easy sticking of tableting processes, into Product aerogenesis is slow, disintegration is slow, and easily the moisture absorption is rotten and cause stability poor during product storage, and shelf life is short, finished product mouth Sense is poor, is difficult the technical problem such as to receive by many patients.
The content of the invention
It is an object of the invention to provide a kind of OXo-1-pyrrolidine acetyl of (S) -4- hydroxyls -2 for being disintegrated fast, good stability Amine effervescent tablet.
Preparation another object of the present invention is to provide the above-mentioned oxo-1-pyrrolidine ethanamide effervescent tablet of (S) -4- hydroxyls -2 Method.
The purpose of the present invention is realized by following technical measures:
It is a kind of to be disintegrated the fast oxo-1-pyrrolidine ethanamide effervescent tablet of (S) -4- hydroxyls -2, it is characterised in that it is with (S) The oxo-1-pyrrolidine ethanamide of -4- hydroxyls -2 be raw material, add a certain amount of acid source, alkali source, adhesive, lubricant, Filler, flavouring are obtained;Wherein described acid source is in citric acid, tartaric acid, fumaric acid, adipic acid, malic acid It is a kind of;The alkali source is the one kind in sodium carbonate, sodium acid carbonate, potassium carbonate, saleratus, calcium carbonate;The bonding Agent is one or more in water, ethanol, sucrose, starch slurry, dextrin, copolyvidone VA64 (PVP/VA64);It is described Lubricant is talcum powder, magnesium stearate, Macrogol 4000, Macrogol 6000, stearic acid, calcium stearate, dodecyl One or more in sodium sulphate, superfine silica gel powder, magnesia, paraffin;Filler is starch, lactose, dextrin, Icing Sugar, sulphur One or more in sour calcium, sucrose, mannitol, microcrystalline cellulose, glucose, sodium carboxymethylcellulose, sodium chloride;It is described Flavouring is sucrose, maltose, ethylmaltol, Sucralose, sweet stevia rebaudianum, sorbierite, mannitol, glucose, A Si One or more in Pa Tan, peppermint oil, strawberry essence, apple banana, peach flavor, chocolate essence.
Inventor has found in research process, suitable supplementary product kind and specific supplementary material consumption proportion relation, then matches somebody with somebody Special preparation method is closed, the oxo-1-pyrrolidine ethanamide effervescent tablet tableting processes of above-mentioned (S) -4- hydroxyls -2 is may be such that not Meeting sticking, finished product aerogenesis is fast, and disintegration is fast, and product storage process is difficult the moisture absorption, and good stability, finished product is in good taste;It is above-mentioned (S) the oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2, it is characterised in that it is by the former auxiliary of following weight proportion Material is obtained:(S) 1 part of -2 oxo-1-pyrrolidine ethanamide of -4- hydroxyls, 5~9 parts of tartaric acid, 5~9 parts of sodium acid carbonate, It is 0.2~0.7 part of sodium chloride, 0.3~1.05 part of Macrogol 6000,5~10 parts of dextrin, 0.7~1.2 part of Sucralose, thin 0.3~0.8 part of lotus oil, 0.3~0.8 part of strawberry essence, 18~25 parts of ethanol solution, the carboxylic that volume fraction is 30%~50% 3~5 parts of sodium carboxymethylcellulose pyce, 6~12 parts of microcrystalline cellulose;The dextrin for taking recipe quantity is placed in and mills, and the quality such as adds Purified water, mixing of milling, in operating process add recipe quantity peppermint oil and strawberry essence, continue to mill 10~20 points Clock, takes out, and is placed in air dry oven, sets 40 DEG C~50 DEG C dryings of drying temperature to moisture and is taken out less than 3%, is placed in In Universalpulverizer, add the oxo-1-pyrrolidine ethanamide of (S) -4- hydroxyls -2 of recipe quantity, tartaric acid, Sucralose, Sodium carboxymethylcellulose, microcrystalline cellulose co-grinding, mixed-powder is collected after crossing 100 mesh sieves, and mixed-powder is placed in Adhesive is added in wet granulator, starts granulator (installing 18 mesh nylon mesh), granulation obtains sour phase particle, standby; Sodium acid carbonate, the sodium chloride mixing of recipe quantity are taken, is placed in Universalpulverizer and is crushed, mixed powder is collected after crossing 100 mesh sieves End, it is standby;The Macrogol 6000 of recipe quantity is heated into fusing, 40~45 DEG C of fusion temperature is set, polyethylene glycol is treated After 6000 fusings, the mixed-powder of above-mentioned sodium acid carbonate and sodium chloride is added, be uniformly mixed, be placed in after cooling omnipotent In pulverizer, crush, be placed in after 100 mesh sieves excessively and adhesive is added in wet granulator, start granulator and (install 18 Mesh nylon mesh), granulation obtains alkali phase particle, standby.
In order to further speed up the oxo-1-pyrrolidine ethanamide Effervescent tablet disintegration aerogenesis speed of (S) -4- hydroxyls -2, improve into Product stability, extends shelf life so that finished product taste is more preferable, the OXo-1-pyrrolidine second of one kind (S) -4- hydroxyls -2 Acid amides effervescent tablet, it is characterised in that it is obtained by the supplementary material of following weight proportion:(S) oxo -1- of -4- hydroxyls -2 1 part of pyrrolidine acetamide, 6~8 parts of tartaric acid, 6~8 parts of sodium acid carbonate, 0.3~0.5 part of sodium chloride, Macrogol 6000 0.45~0.75 part (sodium chloride: Macrogol 6000=2: 3), 7~9 parts of dextrin, 0.9~1.1 part of Sucralose, peppermint 0.5~0.7 part of oil, 0.5~0.8 part of strawberry essence, 19~23 parts of ethanol solution, the carboxylic first that volume fraction is 30%~50% 3~5 parts of base sodium cellulosate, 7~10 parts of microcrystalline cellulose;The dextrin for taking recipe quantity is placed in and mills, and the quality such as adds Purified water, mixing of milling adds the peppermint oil and strawberry essence of recipe quantity in operating process, continue to mill 10~20 minutes, Take out, be placed in air dry oven, 45 DEG C of dryings of drying temperature to moisture is set and is taken out less than 3%, be placed in omnipotent crushing In machine, the oxo-1-pyrrolidine ethanamide of (S) -4- hydroxyls -2, tartaric acid, Sucralose, the carboxymethyl of recipe quantity are added Sodium cellulosate, microcrystalline cellulose co-grinding, mixed-powder is collected after crossing 100 mesh sieves, and mixed-powder is placed in into wet method system Adhesive is added in grain machine, starts granulator (installing 18 mesh nylon mesh), granulation obtains sour phase particle, standby;Take place The sodium acid carbonate of side's amount, sodium chloride mixing, are placed in Universalpulverizer and crush, and mixed-powder is collected after crossing 100 mesh sieves, It is standby;The Macrogol 6000 of recipe quantity is heated into fusing, 42 DEG C of fusion temperature is set, treats that Macrogol 6000 melts Afterwards, the mixed-powder of above-mentioned sodium acid carbonate and sodium chloride is added, is uniformly mixed, be placed in Universalpulverizer after cooling, Crush, be placed in after 100 mesh sieves excessively and adhesive is added in wet granulator, start granulator (installing 18 mesh nylon mesh), Granulation, obtains alkali phase particle, standby.
Supplementary material needed for above-mentioned, is well known to those skilled in the art, and in the market is commercially available.
A kind of preparation method for being disintegrated the fast oxo-1-pyrrolidine ethanamide effervescent tablet of (S) -4- hydroxyls -2, it is characterised in that It is obtained as follows:
1. the dextrin for taking recipe quantity is placed in and mills, and the purified water of quality, mixing of milling, addition in operating process such as adds The peppermint oil and strawberry essence of recipe quantity, continue to mill 10~20 minutes, take out, and are placed in air dry oven, set dry Dry temperature 45 C drying to moisture takes out less than 3%, is placed in Universalpulverizer, adds (the S) -4- hydroxyls -2 of recipe quantity Oxo-1-pyrrolidine ethanamide, tartaric acid, Sucralose, sodium carboxymethylcellulose, microcrystalline cellulose co-grinding, mistake Mixed-powder is collected after 100 mesh sieves, mixed-powder is placed in adhesive is added in wet granulator, start granulator (peace Fill 18 mesh nylon mesh), granulation obtains sour phase particle, standby;
2. sodium acid carbonate, the sodium chloride mixing of recipe quantity are taken, is placed in Universalpulverizer and is crushed, collected after crossing 100 mesh sieves Mixed-powder, it is standby;The Macrogol 6000 of recipe quantity is heated into fusing, 42 DEG C of fusion temperature is set, poly- second two is treated After alcohol 6000 melts, the mixed-powder of above-mentioned sodium acid carbonate and sodium chloride is added, be uniformly mixed, be placed in after cooling In Universalpulverizer, crush, be placed in after 100 mesh sieves excessively and adhesive is added in wet granulator, start granulator and (install 18 mesh nylon mesh), granulation obtains alkali phase particle, standby;
3. in sour phase wet granular, alkali phase wet granular being put into air dry oven respectively, 40 DEG C~50 DEG C of design temperature, control Relative humidity is less than 30%, starts drying;Particle situation is observed at any time, and drying time is 120~150 minutes, it is ensured that Grain moisture≤2%;
4. whole grain, sub-sieve:Sour phase particle is mixed with alkali phase particle and is placed in crushing and pelletizing machine, with 24 mesh sieve whole grains, Below 25 DEG C of environment temperature of control, relative humidity is below 30%;
5. compressing tablet:Tablet press machine pressure, adjustment sheet weight are set, compressing tablet is controlled below 25 DEG C of environment temperature, relative humidity Less than 30%;
6. bag in:(S) the oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2 is packed with Aluminium-coating Packer, setting packaging rule Lattice are 6 sheet panels, and below 25 DEG C of environment temperature of control, below 30%, packaging is obtained final product relative humidity.
The present invention has following beneficial effect:
The present invention is a kind of be disintegrated fast oxo-1-pyrrolidine ethanamide effervescent tablet tableting processes of (S) -4- hydroxyls -2 will not sticking, Finished product aerogenesis is fast, and disintegration rate is fast, and not over 30 seconds, product storage process was difficult moisture absorption and goes bad disintegration time, easily In preservation, and this product is in good taste, is easily received by most of patient, and shelf life is 30 months, preparation technology Simple possible, is worth marketing.
Specific embodiment
The present invention is specifically described below by embodiment, it is necessary to it is pointed out here that be that following examples are served only for The present invention is further described, it is impossible to be interpreted as limiting the scope of the invention, without departing substantially from spirit of the invention In the case of essence, the modification or replacement made to the inventive method, step or condition belong to the scope of the present invention.
Embodiment 1
It is a kind of to be disintegrated the fast oxo-1-pyrrolidine ethanamide effervescent tablet of (S) -4- hydroxyls -2, it is obtained according to the following steps:
Composition Consumption
(S) oxo-1-pyrrolidine ethanamide of -4- hydroxyls -2 1 part
Tartaric acid 6 parts
Sodium acid carbonate 6 parts
Sodium chloride 0.3 part
Macrogol 6000 0.45 part
Dextrin 7 parts
Sucralose 0.9 part
Peppermint oil 0.5 part
Strawberry essence 0.5 part
Volume fraction is 30% ethanol 19 parts
Sodium carboxymethylcellulose 3 parts
Microcrystalline cellulose 7 parts
It is made 1000
Preparation process:
1. the dextrin for taking recipe quantity is placed in and mills, and the purified water of quality, mixing of milling, addition in operating process such as adds The peppermint oil and strawberry essence of recipe quantity, continue to mill 10~20 minutes, take out, and are placed in air dry oven, set dry Dry temperature 45 C drying to moisture takes out less than 3%, is placed in Universalpulverizer, adds (the S) -4- hydroxyls -2 of recipe quantity Oxo-1-pyrrolidine ethanamide, tartaric acid, Sucralose, sodium carboxymethylcellulose, microcrystalline cellulose co-grinding, mistake Mixed-powder is collected after 100 mesh sieves, mixed-powder is placed in adhesive is added in wet granulator, start granulator (peace Fill 18 mesh nylon mesh), granulation obtains sour phase particle, standby;
2. sodium acid carbonate, the sodium chloride mixing of recipe quantity are taken, is placed in Universalpulverizer and is crushed, collected after crossing 100 mesh sieves Mixed-powder, it is standby;The Macrogol 6000 of recipe quantity is heated into fusing, 42 DEG C of fusion temperature is set, poly- second two is treated After alcohol 6000 melts, the mixed-powder of above-mentioned sodium acid carbonate and sodium chloride is added, be uniformly mixed, be placed in after cooling In Universalpulverizer, crush, be placed in after 100 mesh sieves excessively and adhesive is added in wet granulator, start granulator and (install 18 mesh nylon mesh), granulation obtains alkali phase particle, standby;
3. in sour phase wet granular, alkali phase wet granular being put into air dry oven respectively, 40 DEG C~50 DEG C of design temperature, control Relative humidity is less than 30%, starts drying;Particle situation is observed at any time, and drying time is 120~150 minutes, it is ensured that Grain moisture≤2%;
4. whole grain, sub-sieve:Sour phase particle is mixed with alkali phase particle and is placed in crushing and pelletizing machine, with 24 mesh sieve whole grains, Below 25 DEG C of environment temperature of control, relative humidity is below 30%;
5. compressing tablet:Tablet press machine pressure, adjustment sheet weight are set, compressing tablet is controlled below 25 DEG C of environment temperature, relative humidity Less than 30%;
6. bag in:(S) the oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2 is packed with Aluminium-coating Packer, setting packaging rule Lattice are 6 sheet panels, and below 25 DEG C of environment temperature of control, below 30%, packaging is obtained final product relative humidity.
Experiment one:Finished product moisture absorption weightening is determined
1. test material:Embodiment 1 is obtained sample
2. test method:10, sample obtained in Example 1 is respectively placed in relative humidity 75% after being packed by commercially available product Placed 10 days with the environment of relative humidity 92.5%, weighed in sampling in 5 days and 10 days, determine its moisture absorption weightening Rate, investigates the situation of moisture absorption weightening.
3. result of the test:
4. conclusion (of pressure testing):Be can be seen that by upper table result of the test, the prepared sample of the present invention is respectively placed in the He of relative humidity 75% In 92.5% environment, place 10 days moisture absorption rates of body weight gain and be respectively 1.9% and 2.5%, thus product moisture absorption weightening compared with It is small, it is easy to preserve.
Experiment two:Disintegration time limited
1. test material:10, effervescent tablet sample obtained in Example 1, check disintegration time limited.
2. determination method:Test sample 10 is taken, is respectively placed in conical flask, add purified water 50ml, record effervescent tablet to collapse Solution required time completely.
3. result of the test:Disintegration time limited inspection result see the table below:
Sample number into spectrum 1# 2# 3# 4# 5#
Disintegration time (s) 21 26 22 19 28
Sample number into spectrum 6# 7# 8# 9# 10#
Disintegration time 25 23 21 26 23
4. conclusion (of pressure testing):From upper table result of the test, the oxo-1-pyrrolidine ethanamide effervescent tablet of (S) -4- hydroxyls -2 collapses The solution time is respectively less than 30s.
Experiment three:Stability experiment
Experiment material:
(S) the oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2:For embodiment 1 is obtained.
Acceleration study method:By the oxo-1-pyrrolidine ethanamide effervescent tablet of (S) -4- hydroxyls -2 obtained in embodiment 1 by upper City is packed, and puts in Acceleration study case, and certain hour sampling is tested to investigation project.
Acceleration study temperature:40±2℃
Acceleration study humidity:RH75% ± 5%
The investigation time:0th, 1,2,3, June
Inspection target:Proterties, tablet weight variation, disintegration time limited, relevant material, content, microbial limit
Accelerated test stability is recorded:
Acceleration study result shows:Accelerate June sample suitable with 0 month sample items Testing index quality, show that this product adds Speed experiment June, quality keeps stabilization, and this product stability is preferable.
Long-term experiment method:The oxo-1-pyrrolidine ethanamide of (S) -4- hydroxyls -2 obtained in embodiment 1 is packed by listing, Put in the long-term case that keeps sample, certain hour sampling is tested to investigation project.
Long-term experiment temperature:25±2℃
Long-term experiment humidity:RH60% ± 10%
The investigation time:0th, 3,6,9,12,18,24,30 months
Inspection target:Proterties, tablet weight variation, disintegration time limited, relevant material, content, microbial limit
Long term test stability is recorded:
Long term test shows:30 months proterties of this product long term test, tablet weight variation, disintegration time limited, relevant material, contain Amount, microbial limit without significant changes, meet every relevant regulations of production quality standard draft.This product is long-term 30 months steady qualities of experiment, therefore minimum 30 months of this product term of validity, long term test is still during continuing to investigate.
Experiment four:Taste, mouthfeel market survey
The oxo-1-pyrrolidine ethanamide effervescent tablet of the present invention (S) -4- hydroxyls -2 be by specific supplementary material compatibility, it is various to rectify Taste agent coordinates and is made, and with excellent taste, taste is fragrant and sweet, can be received by many patients.
Method:The people of crowd 1000 of random selection more than 10 years old, carries out taste trial test, will now taste result statistics as follows Table:
(S) the oxo-1-pyrrolidine ethanamide effervescent tablet taste application form of -4- hydroxyls -2
It is very good Preferably Typically Difference
591 158 132 119
It can be seen from taste tastes market survey, this product is easy to be received by many patients, according to incompletely statistics, feels taste Road is extraordinary to account for the 59.1% of whole crowd, feel taste it is relatively good account for 15.8%, feel taste it is general account for 13.2%, Think that distasteful accounts for 11.9%.Therefore this product have it is in good taste, easily the characteristics of received by many patients colony.
Embodiment 2
It is a kind of to be disintegrated the fast oxo-1-pyrrolidine ethanamide effervescent tablet of (S) -4- hydroxyls -2, it is obtained according to the following steps:
Composition Consumption
(S) oxo-1-pyrrolidine ethanamide of -4- hydroxyls -2 1 part
Tartaric acid 8 parts
Sodium acid carbonate 8 parts
Sodium chloride 0.5 part
Macrogol 6000 0.75 part
Dextrin 9 parts
Sucralose 1.1 parts
Peppermint oil 0.7 part
Strawberry essence 0.8 part
Volume fraction is 50% ethanol 23 parts
Sodium carboxymethylcellulose 5 parts
Microcrystalline cellulose 10 parts
It is made 1000
Preparation process:Preparation technology according to embodiment 1 is obtained.By the test method of embodiment 1, moisture absorption increasing is carried out respectively Resurveying, fixed, disintegration time limited is checked, sample stability experiment and mouthfeel are investigated, and relative humidity 75% places 10 days products Moisture absorption rate of body weight gain is 1.6%, and it is 2.3% that relative humidity 92.5% places 10 days product moisture absorption rates of body weight gain, shows that finished product is difficult Moisture absorption, disintegration time limited inspection result shows that this product disintegration time is respectively less than 30 seconds, and stability test result shows acceleration 6 Month sample quality stabilization, long-term 30 months steady qualities, therefore this product term of validity at least 30 months, mouthfeel investigation result table Bright this product is in good taste, is easily received by many patients.
Embodiment 3
It is a kind of to be disintegrated the fast oxo-1-pyrrolidine ethanamide effervescent tablet of (S) -4- hydroxyls -2, it is obtained according to the following steps:
Composition Consumption
(S) oxo-1-pyrrolidine ethanamide of -4- hydroxyls -2 1 part
Tartaric acid 7 parts
Sodium acid carbonate 7 parts
Sodium chloride 0.4 part
Macrogol 6000 0.6 part
Dextrin 8 parts
Sucralose 1.0 parts
Peppermint oil 0.6 part
Strawberry essence 0.7 part
Volume fraction is 40% ethanol 21 parts
Sodium carboxymethylcellulose 4 parts
Microcrystalline cellulose 8 parts
It is made 1000
Preparation process:Preparation technology according to embodiment 1 is obtained.By the test method of embodiment 1, moisture absorption increasing is carried out respectively Resurveying, fixed, disintegration time limited is checked, sample stability experiment and mouthfeel are investigated, and relative humidity 75% places 10 days products Moisture absorption rate of body weight gain is 1.8%, and it is 2.4% that relative humidity 92.5% places 10 days product moisture absorption rates of body weight gain, shows that finished product is difficult Moisture absorption, disintegration time limited inspection result shows that this product disintegration time is respectively less than 30 seconds, and stability test result shows acceleration 6 Month sample quality stabilization, long-term 30 months steady qualities, therefore this product term of validity at least 30 months, mouthfeel investigation result table Bright this product is in good taste, is easily received by many patients.
Embodiment 4-6:It is a kind of to be disintegrated the fast oxo-1-pyrrolidine ethanamide effervescent tablet of (S) -4- hydroxyls -2, by following heavy The supplementary material of amount is prepared, and preparation method is with embodiment 1:
Preparation process:Preparation technology according to embodiment 1 is obtained.By the test method of embodiment 1, moisture absorption increasing is carried out respectively Resurveying, fixed, disintegration time limited is checked, sample stability experiment and mouthfeel are investigated, and embodiment 4,5,6 is in relative humidity 75% Place 10 days product moisture absorption rates of body weight gain and be respectively 1.6%, 1.5%, 1.8%, embodiment 4,5,6 is in relative humidity 92.5% Place 10 days product moisture absorption rates of body weight gain and be respectively 2.3%, 2.1%, 2.6%, show that finished product is difficult moisture absorption, embodiment 4,5, 6 disintegration time limited inspection results show that this product disintegration time is respectively less than 30 seconds, the stability test result table of embodiment 4,5,6 Bright acceleration June sample quality stabilization, long-term 30 months steady qualities, therefore this product term of validity at least 30 months, embodiment 4th, the survey showed that this product is in good taste for 5,6 mouthfeels, is easily received by many patients.

Claims (3)

1. a kind of disintegration is fast(S)The oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2, it is characterised in that it is obtained by the supplementary material of following weight proportion:(S)1 part of -2 oxo-1-pyrrolidine ethanamide of -4- hydroxyls, 5 ~ 9 parts of tartaric acid, 5 ~ 9 parts of sodium acid carbonate, 0.2 ~ 0.7 part of sodium chloride, 0.3 ~ 1.05 part of Macrogol 6000,5 ~ 10 parts of dextrin, 0.7 ~ 1.2 part of Sucralose, 0.3 ~ 0.8 part of peppermint oil, 0.3 ~ 0.8 part of strawberry essence, volume fraction are 30% ~ 50% 18 ~ 25 parts of ethanol solution, 3 ~ 5 parts of sodium carboxymethylcellulose, 6 ~ 12 parts of microcrystalline cellulose;The dextrin for taking recipe quantity is placed in and mills, the purified water of the quality such as addition, mill mixing, the peppermint oil and strawberry essence of recipe quantity are added in operating process, continues to mill 10 ~ 20 minutes, taken out, it is placed in air dry oven, set 40 DEG C ~ 50 DEG C dryings of drying temperature to moisture to be taken out less than 3%, be placed in Universalpulverizer, add recipe quantity(S)The oxo-1-pyrrolidine ethanamide of -4- hydroxyls -2, tartaric acid, Sucralose, sodium carboxymethylcellulose, microcrystalline cellulose co-grinding, mixed-powder is collected after crossing 100 mesh sieves, mixed-powder is placed in adhesive is added in wet granulator, starts granulator(18 mesh nylon mesh are installed), granulation obtains sour phase particle, standby;Sodium acid carbonate, the sodium chloride mixing of recipe quantity are taken, is placed in Universalpulverizer and is crushed, mixed-powder is collected after crossing 100 mesh sieves, it is standby;The Macrogol 6000 of recipe quantity is heated into fusing; 40 ~ 45 DEG C of fusion temperature of setting; after after Macrogol 6000 fusing; add the mixed-powder of above-mentioned sodium acid carbonate and sodium chloride; it is uniformly mixed, is placed in Universalpulverizer after cooling, crushes; cross after 100 mesh sieves to be placed in and adhesive is added in wet granulator, start granulator(18 mesh nylon mesh are installed), granulation obtains alkali phase particle, standby.
2. as claimed in claim 1(S)The oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2, it is characterised in that it is obtained by the supplementary material of following weight proportion:(S)1 part of -2 oxo-1-pyrrolidine ethanamide of -4- hydroxyls, 6 ~ 8 parts of tartaric acid, 6 ~ 8 parts of sodium acid carbonate, 0.3 ~ 0.5 part of sodium chloride, 0.45 ~ 0.75 part of Macrogol 6000(Sodium chloride:Macrogol 6000=2:3), 7 ~ 9 parts of dextrin, 0.9 ~ 1.1 part of Sucralose, 0.5 ~ 0.7 part of peppermint oil, 0.5 ~ 0.8 part of strawberry essence, volume fraction for 30% ~ 50% 19 ~ 23 parts of ethanol solution, 3 ~ 5 parts of sodium carboxymethylcellulose, 7 ~ 10 parts of microcrystalline cellulose;The dextrin for taking recipe quantity is placed in and mills, the purified water of the quality such as addition, mill mixing, the peppermint oil and strawberry essence of recipe quantity are added in operating process, continues to mill 10 ~ 20 minutes, taken out, it is placed in air dry oven, set 45 DEG C of dryings of drying temperature to moisture to be taken out less than 3%, be placed in Universalpulverizer, add recipe quantity(S)The oxo-1-pyrrolidine ethanamide of -4- hydroxyls -2, tartaric acid, Sucralose, sodium carboxymethylcellulose, microcrystalline cellulose co-grinding, mixed-powder is collected after crossing 100 mesh sieves, mixed-powder is placed in adhesive is added in wet granulator, starts granulator(18 mesh nylon mesh are installed), granulation obtains sour phase particle, standby;Sodium acid carbonate, the sodium chloride mixing of recipe quantity are taken, is placed in Universalpulverizer and is crushed, mixed-powder is collected after crossing 100 mesh sieves, it is standby;The Macrogol 6000 of recipe quantity is heated into fusing; 42 DEG C of fusion temperature of setting; after after Macrogol 6000 fusing; add the mixed-powder of above-mentioned sodium acid carbonate and sodium chloride; it is uniformly mixed, is placed in Universalpulverizer after cooling, crushes; cross after 100 mesh sieves to be placed in and adhesive is added in wet granulator, start granulator(18 mesh nylon mesh are installed), granulation obtains alkali phase particle, standby.
3. as claimed in claim 1 or 2(S)The preparation method of the oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2, it is characterised in that it is obtained as follows:
A. the dextrin for taking recipe quantity is placed in and mills, the purified water of the quality such as addition, mill mixing, the peppermint oil and strawberry essence of recipe quantity are added in operating process, continues to mill 10 ~ 20 minutes, taken out, it is placed in air dry oven, set 45 DEG C of dryings of drying temperature to moisture to be taken out less than 3%, be placed in Universalpulverizer, add recipe quantity(S)The oxo-1-pyrrolidine ethanamide of -4- hydroxyls -2, tartaric acid, Sucralose, sodium carboxymethylcellulose, microcrystalline cellulose co-grinding, mixed-powder is collected after crossing 100 mesh sieves, mixed-powder is placed in adhesive is added in wet granulator, starts granulator(18 mesh nylon mesh are installed), granulation obtains sour phase particle, standby;
B. sodium acid carbonate, the sodium chloride mixing of recipe quantity are taken, is placed in Universalpulverizer and is crushed, mixed-powder is collected after crossing 100 mesh sieves, it is standby;The Macrogol 6000 of recipe quantity is heated into fusing; 42 DEG C of fusion temperature of setting; after after Macrogol 6000 fusing; add the mixed-powder of above-mentioned sodium acid carbonate and sodium chloride; it is uniformly mixed, is placed in Universalpulverizer after cooling, crushes; cross after 100 mesh sieves to be placed in and adhesive is added in wet granulator, start granulator(18 mesh nylon mesh are installed), granulation obtains alkali phase particle, standby;
C. in sour phase wet granular, alkali phase wet granular being put into air dry oven respectively, 40 DEG C ~ 50 DEG C of design temperature, control relative humidity is less than 30%, starts drying;Particle situation is observed at any time, and drying time is 120 ~ 150 minutes, it is ensured that pellet moisture≤2%;
D. whole grain, sub-sieve:Sour phase particle is mixed with alkali phase particle and is placed in crushing and pelletizing machine, with 24 mesh sieve whole grains, below 25 DEG C of environment temperature of control, relative humidity is below 30%;
E. compressing tablet:Tablet press machine pressure, adjustment sheet weight are set, compressing tablet is controlled below 25 DEG C of environment temperature, and relative humidity is below 30%;
F. interior bag:(S)The oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2 is packed with Aluminium-coating Packer, sets packing specification as 6 sheet panels, and below 25 DEG C of environment temperature of control, below 30%, packaging is obtained final product relative humidity.
CN201510946805.XA 2015-12-17 2015-12-17 A kind of disintegration is fast(S)Oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2 and preparation method thereof Withdrawn CN106902092A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510946805.XA CN106902092A (en) 2015-12-17 2015-12-17 A kind of disintegration is fast(S)Oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2 and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510946805.XA CN106902092A (en) 2015-12-17 2015-12-17 A kind of disintegration is fast(S)Oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2 and preparation method thereof

Publications (1)

Publication Number Publication Date
CN106902092A true CN106902092A (en) 2017-06-30

Family

ID=59200561

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510946805.XA Withdrawn CN106902092A (en) 2015-12-17 2015-12-17 A kind of disintegration is fast(S)Oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2 and preparation method thereof

Country Status (1)

Country Link
CN (1) CN106902092A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2044216A5 (en) * 1969-05-12 1971-02-19 Ile De France Effervescent tablets prepd by aqueous - granulation
CN101766595A (en) * 2008-12-31 2010-07-07 北京利乐生制药科技有限公司 Solid preparation with levo-oxiracetam as active component
CN101766596A (en) * 2009-01-04 2010-07-07 北京润德康医药技术有限公司 Solid preparation with dextro-oxiracetam as active component
CN103301114A (en) * 2012-03-07 2013-09-18 辽宁亿灵科创生物医药科技有限公司 Oxiracetam medicinal composition, and preparation method and application thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2044216A5 (en) * 1969-05-12 1971-02-19 Ile De France Effervescent tablets prepd by aqueous - granulation
CN101766595A (en) * 2008-12-31 2010-07-07 北京利乐生制药科技有限公司 Solid preparation with levo-oxiracetam as active component
CN101766596A (en) * 2009-01-04 2010-07-07 北京润德康医药技术有限公司 Solid preparation with dextro-oxiracetam as active component
CN103301114A (en) * 2012-03-07 2013-09-18 辽宁亿灵科创生物医药科技有限公司 Oxiracetam medicinal composition, and preparation method and application thereof

Similar Documents

Publication Publication Date Title
EP3679010B1 (en) Carbonic acid adducts
CN104434864B (en) A kind of medicine effervescent tablet and preparation method thereof
CN104334166A (en) Pharmaceutical composition for the prophylaxis and treatment of psychological, behavioral and cognitive disorders
DE102016014603A1 (en) Synthetic ayahuasca
CN105878197A (en) Riociguat orally disintegrating tablet and preparation method thereof
US20220312826A1 (en) Liquid mixtures of triglyceride and liquid nicotine
CN106902092A (en) A kind of disintegration is fast(S)Oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2 and preparation method thereof
CN104739796B (en) A kind of Oxiracetam tablet and preparation method thereof
CN106902091A (en) A kind of delicious levo-oxiracetam effervescent tablet and preparation method thereof
CN106902090A (en) It is a kind of in good taste(S)Oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2 and preparation method thereof
CN106890152A (en) A kind of levo-oxiracetam effervescent tablet in good taste and preparation method thereof
CN106890151A (en) A kind of levo-oxiracetam effervescent tablet of good stability and preparation method thereof
CN106890153A (en) A kind of good stability(S)Oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2 and preparation method thereof
CN106890155A (en) It is a kind of(S)Oxo-1-pyrrolidine ethanamide effervescent tablet of -4- hydroxyls -2 and preparation method thereof
CN106890154A (en) A kind of levo-oxiracetam effervescent tablet and preparation method thereof
CN106890157A (en) It is a kind of to be difficult levo-oxiracetam effervescent tablet of moisture absorption and preparation method thereof
CN106619524A (en) Good-stability sinistral oxiracetam and preparation method thereof
CN107510654A (en) It is a kind of in good taste(S)Oxo-1-pyrrolidine ethanamide particle of -4- hydroxyls -2 and preparation method thereof
CN106619528A (en) (S)-4-hydroxy-2oxo-1-pyrrolidine acetamide particle with good mouthfeel and preparation method thereof
CN107510680A (en) It is a kind of in good taste(S)Pyrrolidine acetamide particle of 4 hydroxyl, 2 oxo 1 and preparation method thereof
CN107510662A (en) A kind of oxo-1-pyrrolidine ethanamide particle of (S) -4- hydroxyls -2 in good taste and preparation method thereof
CN106606485A (en) Good taste levo S-oxiracetam particle and preparation method thereof
CN106619526A (en) Good-stability (S)-4-hydroxy-2 oxo-1-pyrrolidine acetamide granule and preparation method thereof
TW201740947A (en) Oral solid preparation comprising aripiprazole and method for producing oral solid preparation comprising aripiprazole
CN106890156A (en) It is a kind of to be disintegrated fast levo-oxiracetam effervescent tablet and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20170630